Literature DB >> 17499733

An automated one-step one-pot [(18)F]FCWAY synthesis: development and minimization of chemical impurities.

Bik-Kee Vuong1, Dale O Kiesewetter, Lixin Lang, Ying Ma, William C Eckelman, Michael A Channing.   

Abstract

[(18)F]FCWAY (N-{2-[4-(2-methoxyphenyl)piperazino]}-N-(2-pyridinyl)trans-4-fluorocyclohexanecarboxamide) has been prepared routinely as a serotonin 5-HT(1A) receptor ligand for clinical human studies. We have developed an automated one-step radiosynthesis using a modified Nuclear Interface C-11 Methylation System. The chemical synthesis of an appropriate methanesulfonate precursor for single-step nucleophilic substitution with [(18)F]fluoride ion and the adaptation of radiochemical synthesis to an automated production module were accomplished. Following purification of a substrate using countercurrent chromatography, radiochemical yield increased from 18.9+/-0.3% to 21.9+/-2.2%. In addition, reduction of chemical impurities from about 40% to about 20% of total mass was observed. Further improvements in chemical purity were achieved by minimization of side reactions by modification of reaction conditions and optimization of the high-performance liquid chromatography method for the purification of the final radiopharmaceutical. Optimized automated synthesis produced [(18)F]FCWAY in a radiochemical yield of 28+/-6% at a chemical purity of 99.3% based on the absorbance of FCWAY at 254 nm and with a specific activity of 3433+/-1015 mCi/micromol at the end of bombardment, all calculated from the same 50 runs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17499733      PMCID: PMC1994052          DOI: 10.1016/j.nucmedbio.2007.03.001

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  11 in total

1.  Development of fluorine-18-labeled 5-HT1A antagonists.

Authors:  L Lang; E Jagoda; B Schmall; B K Vuong; H R Adams; D L Nelson; R E Carson; W C Eckelman
Journal:  J Med Chem       Date:  1999-05-06       Impact factor: 7.446

2.  Purification of the precursor for the automated radiosynthesis of [18F]FCWAY by counter-current chromatography.

Authors:  Ying Ma; Lixin Lang; Dale O Kiesewetter; Bik-Kee Vuong; Michael Channing; Yoichiro Ito; William C Eckelman
Journal:  J Chromatogr A       Date:  2004-04-23       Impact factor: 4.759

3.  PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy.

Authors:  M T Toczek; R E Carson; L Lang; Y Ma; M V Spanaki; M G Der; S Fazilat; L Kopylev; P Herscovitch; W C Eckelman; W H Theodore
Journal:  Neurology       Date:  2003-03-11       Impact factor: 9.910

4.  [11C]WAY 100635: a radioligand for imaging 5-HT1A receptors with positron emission tomography.

Authors:  C A Mathis; N R Simpson; K Mahmood; P E Kinahan; M A Mintun
Journal:  Life Sci       Date:  1994       Impact factor: 5.037

5.  No change in serotonin type 1A receptor binding in patients with posttraumatic stress disorder.

Authors:  Omer Bonne; Earle Bain; Alexander Neumeister; Allison C Nugent; Meena Vythilingam; Richard E Carson; David A Luckenbaugh; William Eckelman; Peter Herscovitch; Wayne C Drevets; Dennis S Charney
Journal:  Am J Psychiatry       Date:  2005-02       Impact factor: 18.112

6.  PET evaluation of [(18)F]FCWAY, an analog of the 5-HT(1A) receptor antagonist, WAY-100635.

Authors:  R E Carson; L Lang; H Watabe; M G Der; H R Adams; E Jagoda; P Herscovitch; W C Eckelman
Journal:  Nucl Med Biol       Date:  2000-07       Impact factor: 2.408

7.  Brain uptake of the acid metabolites of F-18-labeled WAY 100635 analogs.

Authors:  Richard E Carson; Yanjun Wu; Lixin Lang; Ying Ma; Margaret G Der; Peter Herscovitch; William C Eckelman
Journal:  J Cereb Blood Flow Metab       Date:  2003-02       Impact factor: 6.200

8.  Reduced serotonin type 1A receptor binding in panic disorder.

Authors:  Alexander Neumeister; Earle Bain; Allison C Nugent; Richard E Carson; Omer Bonne; David A Luckenbaugh; William Eckelman; Peter Herscovitch; Dennis S Charney; Wayne C Drevets
Journal:  J Neurosci       Date:  2004-01-21       Impact factor: 6.167

9.  Determination of [18F]FCWAY, [18F]FP-TZTP, and their metabolites in plasma using rapid and efficient liquid-liquid and solid phase extractions.

Authors:  Ying Ma; Dale O Kiesewetter; Lixin Lang; Margaret Der; Bill Huang; Richard E Carson; William C Eckelman
Journal:  Nucl Med Biol       Date:  2003-04       Impact factor: 2.408

10.  The automated radiosynthesis of [18F]FP-TZTP.

Authors:  Dale O Kiesewetter; Bik-kee Vuong; Michael A Channing
Journal:  Nucl Med Biol       Date:  2003-01       Impact factor: 2.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.